315 related articles for article (PubMed ID: 12225654)
1. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist.
Tehranian R; Andell-Jonsson S; Beni SM; Yatsiv I; Shohami E; Bartfai T; Lundkvist J; Iverfeldt K
J Neurotrauma; 2002 Aug; 19(8):939-51. PubMed ID: 12225654
[TBL] [Abstract][Full Text] [Related]
2. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist.
Lundkvist J; Sundgren-Andersson AK; Tingsborg S; Ostlund P; Engfors C; Alheim K; Bartfai T; Iverfeldt K; Schultzberg M
Am J Physiol; 1999 Mar; 276(3):R644-51. PubMed ID: 10070123
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay C; Smith MF; Eidlen D; Arend WP
J Clin Invest; 1997 Jun; 99(12):2930-40. PubMed ID: 9185517
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse.
Oprica M; Van Dam AM; Lundkvist J; Iverfeldt K; Winblad B; Bartfai T; Schultzberg M
Acta Neuropathol; 2004 Jul; 108(1):69-80. PubMed ID: 15138779
[TBL] [Abstract][Full Text] [Related]
5. Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice.
Goujon E; Parnet P; Laye S; Combe C; Kelley KW; Dantzer R
Brain Behav Immun; 1995 Dec; 9(4):292-303. PubMed ID: 8903847
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury.
Knoblach SM; Faden AI
Exp Neurol; 1998 Sep; 153(1):143-51. PubMed ID: 9743576
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage.
Campuzano O; Castillo-Ruiz MM; Acarin L; Castellano B; Gonzalez B
J Neurosci Res; 2009 Aug; 87(11):2484-97. PubMed ID: 19326443
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury.
Perez-Polo JR; Rea HC; Johnson KM; Parsley MA; Unabia GC; Xu GY; Prough D; DeWitt DS; Paulucci-Holthauzen AA; Werrbach-Perez K; Hulsebosch CE
J Neurosci Res; 2016 Jan; 94(1):27-38. PubMed ID: 26172557
[TBL] [Abstract][Full Text] [Related]
9. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury.
He J; Evans CO; Hoffman SW; Oyesiku NM; Stein DG
Exp Neurol; 2004 Oct; 189(2):404-12. PubMed ID: 15380490
[TBL] [Abstract][Full Text] [Related]
10. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury.
Yatsiv I; Morganti-Kossmann MC; Perez D; Dinarello CA; Novick D; Rubinstein M; Otto VI; Rancan M; Kossmann T; Redaelli CA; Trentz O; Shohami E; Stahel PF
J Cereb Blood Flow Metab; 2002 Aug; 22(8):971-8. PubMed ID: 12172382
[TBL] [Abstract][Full Text] [Related]
11. Temporal profile of M1 and M2 responses in the hippocampus following early 24h of neurotrauma.
Ansari MA
J Neurol Sci; 2015 Oct; 357(1-2):41-9. PubMed ID: 26148932
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice.
Clausen F; Hånell A; Israelsson C; Hedin J; Ebendal T; Mir AK; Gram H; Marklund N
Eur J Neurosci; 2011 Jul; 34(1):110-23. PubMed ID: 21623956
[TBL] [Abstract][Full Text] [Related]
13. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
14. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
[TBL] [Abstract][Full Text] [Related]
15. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes.
Jones NC; Prior MJ; Burden-Teh E; Marsden CA; Morris PG; Murphy S
Eur J Neurosci; 2005 Jul; 22(1):72-8. PubMed ID: 16029197
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
[TBL] [Abstract][Full Text] [Related]
18. Purinergic 2Y1 receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model.
Talley Watts L; Sprague S; Zheng W; Garling RJ; Jimenez D; Digicaylioglu M; Lechleiter J
J Neurotrauma; 2013 Jan; 30(1):55-66. PubMed ID: 23046422
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of toll-like receptor 2 reduces secondary brain injury caused by cortical contusion in mice.
Yu ZQ; Zha JH
Ann Clin Lab Sci; 2012; 42(1):26-33. PubMed ID: 22371907
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of hippocampal chemical-induced injury response by ebselen, pentoxifylline, and TNFalpha-, IL-1alpha-, and IL-6-neutralizing antibodies.
Jean Harry G; Bruccoleri A; Lefebvre d'Hellencourt C
J Neurosci Res; 2003 Aug; 73(4):526-36. PubMed ID: 12898537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
